Filing Details
- Accession Number:
- 0001140361-10-043950
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-05 13:00:00
- Reporting Period:
- 2010-11-04
- Filing Date:
- 2010-11-05
- Accepted Time:
- 2010-11-05 16:20:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380710 | Eric George Davis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-10-29 | 371 | $11.64 | 28,272 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2010-11-04 | 10,000 | $11.74 | 38,272 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-04 | 10,000 | $25.83 | 28,272 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-11-04 | 371 | $25.90 | 27,901 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2010-11-04 | 10,000 | $0.00 | 10,000 | $11.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 307,000 | 2006-07-06 | 2016-01-05 | No | 4 | M | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2010 to October 29, 2010.
- In accordance with the ESPP, these shares have been purchased at 85% of the closing price of issuer's common stock on October 29, 2010.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $25.80 to $25.90. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $25.9009 to $25.9010. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vested 6/48ths on 7/6/2006 and 1/48th on the 6th day of every month thereafter.
Billionaire Hedge Funds
